Meniett Therapy
Meniett therapy is safe, simple, and effective for Ménière’s disease dizziness and vertigo
Detail
– If diet and medications don't help your Ménière's disease, Meniett therapy may help you avoid surgical or destructive treatmentsurgeryThe Meniett device was invented in the 1990s and is based on nearly 30 years of clinical research.1-16 It’s considered a second-level treatment for Ménière's disease.
The Meniett device sends painless micropressure pulses into the ear that may reduce fluid and swelling in the inner ear to relieve severe dizziness/vertigo.1-12 See how the Meniett device works
The American Academy of Otolaryngology is the world’s largest organization of ear, nose, and throat (ENT) specialists. It supports using this type of therapy in certain cases of Ménière's disease, especially after diet/medical therapy hasn’t helped.17
Learn more about Meniett therapy
References
- Dornhoffer JL, King D. The effect of the Meniett device in patients with Ménière's disease: long-term results. Otol Neurotol 2008; 29(6):868-74.
- Mattox DE, Reichert M. Meniett device for Ménière's disease: use and compliance at 3 to 5 years. Otol Neurotol 2008; 29(1):29-32.
- Weining H, Fang L, Bo G, Jinmei Z. Clinical long-term effects of Meniett pulse generator for Ménière's disease. Acta Otolaryngol 2009; 129(8): 819-825.
- Barbara M, Monini S, Chiappini I, Filipo R. Meniett therapy may avoid vestibular neurectomy in disabling Ménière's disease. Acta Otolaryngol 2007; 127(11):1136-1141.
- Nabi S, Parnes LS. Bilateral Ménière’s disease. Curr Opin Otolaryngol Head Neck Surg 2009; 17:356-362.
- Thomsen J, Sass K, Ödkvist L, Arlinger S. Local over-pressure treatment reduces vestibular symptoms in patients with Ménière’s disease: a clinical, randomized, multicenter, double-blind, placebo-controlled study. Otol Neurotol 2005; 26:68-73.
- Rajan GP, Din S, Atlas MD. Long-term effects of the Meniett device in Ménière’s disease: the Western Australian experience. J Laryngol Otol 2005; 119:391-395.
- Densert B, Sass K. Control of symptoms in patients with Ménière’s disease using middle ear applications: A two-year follow-up. Acta Otolaryngol 2001; 121(5):616-621.
- Gates GA, Green Jr. JD, Tucci DL, Telian SA. The effects of transtympanic micropressure treatment in people with unilateral Ménière’s disease. Arch of Oto – HNS 2004; 130(6):718-725.
- Gates GA, Verrall A, Green Jr. JD, Tucci DL, Telian SA. Meniett clinical trial: long-term follow-up. Arch Otolaryngol Head Neck Surg 2006; 132:1311-1316.
- Ödkvist LM, Arlinger S, Billermark E, Densert B, Lindholm S, Wallquist J. Effects of middle ear pressure changes on clinical symptoms in patients with Ménière’s disease: A clinical, multicenter, placebo-controlled study. Acta Otolaryngol Suppl 2000; 543: 99-101.
- Densert B, Densert O, Arlinger S, Sass K, Ödkvist LM. Immediate effects of middle ear pressure changes on the electrocochleographic recordings in patients with Ménière’s disease: A clinical placebo-controlled study. Am J Otol 1997; 18:726-733.
- Densert B, Densert O. Overpressure in treatment of Ménière’s disease. Laryngoscope 1982; 92:1285-1292.
- Densert B. Effects of overpressure on hearing function in Ménière’s disease. Acta Otolaryngol (Stockh) 1987; 103:32-42.
- Feijen RA, Segenhout JM, Wit HP, Albers FWJ. Monitoring inner ear pressure changes in normal guinea pigs induced by the Meniett 20. Acta Otolaryngol 2000; 804-809.
- Densert B, Sass K, Arlinger S. Short-term effects of induced middle ear pressure changes on the electrocochleogram in Ménière’s disease. Acta Otolaryngol (Stockh) 1995; 115: 732-737.
- Committee on Equilibrium of the American Academy of Otolaryngology–Head and Neck Surgery: Micropressure Therapy Policy Statement. March 2008.
Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.
- Print Page
- E-mail Page
- A
- A
- A Text Size
